Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Novo Nordisk launches anti-obesity drug Wegovy in India

by AIP Online Bureau | Jun 24, 2025 | Health, Indian News

“We have an India-specific price with the benefit of the same price for the first three dosing strengths. With this we are reaffirming our commitment to address India’s growing burden of overweight and obesity,” Novo Nordisk India Managing Director...

Too much insulin can be as dangerous as too little: Research

by AIP Online Bureau | Apr 23, 2023 | Facts, Health, Workplace/Employee Benefits

While our body finely tunes insulin production, patients who are treated with insulin or drugs that stimulate insulin secretion often experience hypoglycemia, a condition that if gone unrecognized and untreated can result in seizures, coma and even death, which...

Recent Posts

  • South Korean pension fund seeks India government bond investment licence
  • MeitY Secretary urges Microsoft to locate future data centres closer to power generation hubs
  • India studying new US law on sanctions against Russian oil buyers: Piyush Goyal
  • Hormuz shuttles keep oil flowing, but at a high cost
  • Soaring cost making some long-distance crude trades uneconomical

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy